Leukeran (chlorambucil)

chlorambucil · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Leukeran (chlorambucil), covering 2023-01-10 to 2023-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL [Phase 3]